PubRank

Breast disease (Breast Dis)

Journal PubWeight™ 202.65‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Epidemiology of inflammatory breast cancer (IBC). 2006 2.46
2 Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. 2010 1.64
3 Epidemiology of breast cancer in young women. 2006 1.63
4 Mammographic densities and breast cancer risk. 1998 1.49
5 A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. 2007 1.49
6 Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. 2007 1.47
7 Lifetime reproductive and anthropometric risk factors for breast cancer in postmenopausal women. 2006 1.33
8 Psychosocial issues confronting young women with breast cancer. 2006 1.30
9 Medical applications of diffraction enhanced imaging. 1998 1.28
10 Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. 2007 1.28
11 Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs). 2006 1.22
12 Brain metastases of breast cancer. 2007 1.20
13 Chemokine networks and breast cancer metastasis. 2007 1.17
14 Endogenous hormones and risk of breast cancer in postmenopausal women. 2006 1.16
15 Progestins and breast cancer. 2006 1.16
16 Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. 2007 1.16
17 Chemical carcinogenesis of rat and mouse mammary glands. 2007 1.14
18 Tumor biology of breast cancer in young women. 2006 1.13
19 Hypoxia and metastasis in breast cancer. 2007 1.11
20 Integromic analysis of the NCI-60 cancer cell lines. 2004 1.08
21 Psychosocial and behavioral impact of genetic counseling and testing. 2007 1.08
22 Clinical and epidemiologic profile of breast cancer in Tanzania. 2010 1.05
23 Current treatment options in triple negative breast cancer. 2010 1.04
24 Clinical aspects of inflammatory breast cancer. 2006 1.03
25 Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. 2008 1.03
26 BRCA1/2 mutations and triple negative breast cancers. 2010 0.99
27 Comparative pathology of mammary gland cancers in domestic and wild animals. 2007 0.99
28 Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells. 2003 0.99
29 Long-term complications of adjuvant chemotherapy for early stage breast cancer. 2004 0.98
30 Skeletal muscle metastasis from breast cancer: management and literature review. 2015 0.98
31 Small bowel obstruction from breast cancer metastasis: a case report and review of the literature. 2013 0.97
32 Role of IGF-1R in mediating breast cancer invasion and metastasis. 2003 0.96
33 TGF-beta in mammary gland development and breast cancer. 2003 0.95
34 Glycoprotein tumor antigens for immunotherapy of breast cancer. 2004 0.94
35 New tricks against an old foe: molecular dissection of metastasis tissue tropism in breast cancer. 2007 0.94
36 The rat oncogenome: comparative genetics and genomics of rat models of mammary carcinogenesis. 2007 0.94
37 Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. 2003 0.93
38 Development of functional electron paramagnetic resonance imaging. 1998 0.93
39 Life after BRCA1/2 testing: family communication and support issues. 2007 0.93
40 Breast tuberculosis: rare but still present in Italy--a case of mycobacterium breast infection. 2013 0.92
41 Primary chondrosarcoma of the breast: report of a case and review of the literature. 2013 0.92
42 Clinical trials in triple negative breast cancer. 2010 0.92
43 Cross talk between estrogen receptor and IGF signaling in normal mammary gland development and breast cancer. 2003 0.92
44 Inflammatory breast cancer: current concepts in local management. 2006 0.92
45 Implant-based breast reconstruction following mastectomy. 2002 0.91
46 Support for the selective chromatid segregation hypothesis advanced for the mechanism of left-right body axis development in mice. 2008 0.91
47 Heat shock protein 90 is a rational molecular target in breast cancer. 2002 0.91
48 Mondor's disease of the breast. A retrospective review. 2011 0.91
49 Her-2/neu as a paradigm of a tumor-specific target for therapy. 2004 0.90
50 Role of prolactin/prolactin receptor signaling in human breast cancer. 2003 0.90
Next 50